Are We Making Progress in Preventing Barrett's-Related Esophageal Cancer?

Por Abrams, Julian A.
Publicado em 2009

Chemoprevention of Esophageal Adenocarcinoma

Por Abrams, Julian A.
Publicado em 2008

Emerging Insights into the Esophageal Microbiome

Por May, Michael, Abrams, Julian A.
Publicado no Curr Treat Options Gastroenterol (2018)

Clostridium difficile infection in the community: Are proton pump inhibitors to blame?

Por Freedberg, Daniel E, Abrams, Julian A
Publicado em 2013

Recent Therapeutic Advances in Gastroenterology and Hepatology

Por Freedberg, Daniel E., Abrams, Julian A.
Publicado em 2013

DIVERGING TRENDS IN THE INCIDENCE OF REFLUX-RELATED AND HELICOBACTER PYLORI-RELATED GASTRIC CARDIA CANCER

Por Abrams, Julian A., Gonsalves, Lou, Neugut, Alfred I.
Publicado em 2013

The Rapid Rise in Gastroesophageal Junction Tumors: Is Inflammation of the Gastric Cardia the Underwater Iceberg?

Por QUANTE, MICHAEL, ABRAMS, JULIAN A., WANG, TIMOTHY C.
Publicado em 2013

The impact of proton pump inhibitors on the human gastrointestinal microbiome

Por Freedberg, Daniel E., Lebwohl, Benjamin, Abrams, Julian A.
Publicado no Clin Lab Med (2014)

Epidemiology of Barrett’s Esophagus and Esophageal Adenocarcinoma

Por Runge, Thomas M., Abrams, Julian A., Shaheen, Nicholas J.
Publicado no Gastroenterol Clin North Am (2015)

Potential Role of the Microbiome in Barrett's Esophagus and Esophageal Adenocarcinoma

Por Snider, Erik J., Freedberg, Daniel E., Abrams, Julian A.
Publicado no Dig Dis Sci (2016)

Barrett esophagus: What a mouse model can teach us about human disease

Por Quante, Michael, Abrams, Julian A., Lee, Yoomi, Wang, Timothy C.
Publicado em 2012

An automated tool for detecting medication overuse based on the electronic health records

Por Salmasian, Hojjat, Freedberg, Daniel E, Abrams, Julian A, Friedman, Carol
Publicado em 2012

Proton Pump Inhibitors and Risk for Recurrent Clostridium Difficile Infection Among Inpatients

Por Freedberg, Daniel E., Salmasian, Hojjat, Friedman, Carol, Abrams, Julian A.
Publicado em 2013

Racial and Ethnic Disparities in the Prevalence of Barrett’s Esophagus Among Patients Who Undergo Upper Endoscopy

Por ABRAMS, JULIAN A., FIELDS, SYDNEY, LIGHTDALE, CHARLES J., NEUGUT, ALFRED I.
Publicado em 2007

Orders for intravenous proton pump inhibitors decrease after implementation of an electronic alert

Por Freedberg, Daniel E., Salmasian, Hojjat, Abrams, Julian A., Green, Robert A.
Publicado no JAMA Intern Med (2015)

Cost-Effectiveness of Chemoprevention with Proton Pump Inhibitors in Barrett’s Esophagus

Por Sharaiha, Reem Z., Freedberg, Daniel E., Abrams, Julian A., Wang, Y. Claire
Publicado no Dig Dis Sci (2014)

Receipt of antibiotics in hospitalized patients and risk for Clostridium difficile infection in subsequent patients who occupy the same bed

Por Freedberg, Daniel E., Salmasian, Hojjat, Cohen, Bevin, Abrams, Julian A., Larson, Elaine L.
Publicado no JAMA Intern Med (2016)

Dating the Rise of Esophageal Adenocarcinoma: Analysis of Connecticut Tumor Registry Data, 1940–2007

Por Abrams, Julian A., Sharaiha, Reem Z., Gonsalves, Lou, Lightdale, Charles J., Neugut, Alfred I.
Publicado em 2010

Cigarette Smoking and Risk of Lung Metastasis from Esophageal Cancer

Por Abrams, Julian A., Lee, Paul C., Port, Jeffrey L., Altorki, Nasser K., Neugut, Alfred I.
Publicado em 2008

Safety, tolerability, and efficacy of endoscopic low-pressure liquid nitrogen spray cryotherapy in the esophagus

Por Greenwald, Bruce D., Dumot, John A., Horwhat, J. David, Lightdale, Charles J., Abrams, Julian A.
Publicado em 2009